Shape Therapeutics
3 known investors
ShapeTX develops programmable RNA medicines by combining artificial intelligence with RNA technology to address genetic causes of disease.
Founders & leadership
JV
Josef von Rickenbach, PhDinCo-Founder
Investors · 3
In the news
- Shape Raises $112M for RNA-based Gene Therapies for Rett, Like Illsrettsyndromenews.com · 2021
- Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapyglobenewswire.com · 2021
- Shape Therapeutics Gets $35.5m In Funding For RNA-Gene Editing Technology - Healthcare Weeklyhealthcareweekly.com · 2019
- Shape Therapeutics, Inc. raises $35.5M Series A financing, led by NEA and announces the formation of a world-class Scientific Advisory Board, to advance a first-in-class RNA editing gene therapy platform focused on curing genetic diseases. - CureDuchennecureduchenne.org · 2019